Company Filing History:
1 out of 1,745 
1 out of 33 
1 out of 1 Years Active: 2019
Title: Sylvain Mareschal: Innovator in Lymphoma Classification
Introduction
Sylvain Mareschal is a notable inventor based in Rouen, France. He has made significant contributions to the field of medical research, particularly in the classification of diffuse large B-cell lymphomas (DLBCLs). His innovative methods have the potential to enhance diagnostic accuracy and treatment strategies for patients suffering from this type of cancer.
Latest Patents
Mareschal holds a patent for a method that classifies diffuse large B-cell lymphomas into GCB-DLBCLs or ABC-DLBCLs. This invention involves determining the expression level of ten specific genes in tumor tissue samples. The genes involved in this classification are NEK6, IRF4, IGHM, LMO2, FOXP1, TNFRSF9, BCL6, TNFRSF13B, CCND2, and MYBL1. The method utilizes a Reverse Transcriptase Multiplex Ligation dependent Probe Amplification (RT-MLPA) assay, which is a sophisticated technique for analyzing gene expression.
Career Highlights
Throughout his career, Sylvain Mareschal has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Rouen (Université De Rouen). His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mareschal has collaborated with notable colleagues, including Fabrice Jardin and Philippe Ruminy. These partnerships have facilitated the advancement of research in lymphoma classification and have contributed to the development of innovative diagnostic methods.
Conclusion
Sylvain Mareschal's contributions to the field of lymphoma classification exemplify the impact of innovative research in medicine. His patented methods and collaborations with esteemed institutions highlight his commitment to improving patient outcomes through scientific advancement.